<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">In 2015 and 2016, Zika virus (ZIKV) swept through many Latin American countries
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup> where dengue virus (DENV) is endemic. Following this epidemic, many locations appeared to experience abnormally low dengue incidence. DENV and ZIKV share a vector
 <sup>
  <xref ref-type="bibr" rid="CR2">2</xref>,
  <xref ref-type="bibr" rid="CR3">3</xref>
 </sup> and are both flaviviruses. Evidence suggests these viruses may interact competitively or synergistically through human immune responses: via antibodies in the case of non-overlapping infections
 <sup>
  <xref ref-type="bibr" rid="CR4">4</xref>–
  <xref ref-type="bibr" rid="CR10">10</xref>
 </sup> or innate defenses during co-infections
 <sup>
  <xref ref-type="bibr" rid="CR11">11</xref>,
  <xref ref-type="bibr" rid="CR12">12</xref>
 </sup>. Concurrent infections in the vector could also potentially alter viral fitness though the low prevalence of infection in mosquitos at any time and thus the low rate at which concurrent infections occur is likely to minimize the impact of this interaction
 <sup>
  <xref ref-type="bibr" rid="CR12">12</xref>–
  <xref ref-type="bibr" rid="CR14">14</xref>
 </sup>. It is also possible that these viruses may have no biological interaction whatsoever. Changes in surveillance and control in response to Zika
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>,
  <xref ref-type="bibr" rid="CR15">15</xref>
 </sup> could affect reported dengue cases. Conditions (climate
 <sup>
  <xref ref-type="bibr" rid="CR16">16</xref>
 </sup>, vector abundance) that favor Zika may be similar to those favoring dengue.
</p>
